Xenon Pharmaceuticals (NASDAQ:XENE) Price Target Raised to $

Xenon Pharmaceuticals (NASDAQ:XENE – Get Rating) had its target price boosted by Stifel Nicolaus from $52.00 to $53.00 in a research report released on Wednesday morning, The Fly reports. Several other equities research analysts have also recently issued reports on XENE. StockNews.com initiated coverage on Xenon Pharmaceuticals in a report on Thursday, March 16th. They […]

Related Keywords

Canada , Simonn Pimstone , Simon Neil Pimstone , Stifel Nicolaus , Jpmorgan Chase Co , Marshall Wace , Goldman Sachs Group Inc , Cantor Fitzgerald , Needham Company , Xenon Pharmaceuticals Stock Performance , Analyst Recommendations For Xenon Pharmaceuticals , Royal Bank , News Ratings For Xenon Pharmaceuticals Daily , Xenon Pharmaceuticals Inc , Xenon Pharmaceuticals , Get Rating , Moderate Buy , Director Simon , Sachs Group , Logos Global Management , Xenon Pharmaceuticals Daily , Nasdaq Xene , Exene , Medical , Boost Price Target ,